Symbols / YI Stock $6.07 +5.20% 111, Inc.

Healthcare • Medical Distribution • China • NGM
YI (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Distribution
CEO Mr. Junling Liu
Exch · Country NGM · China
Market Cap 53.40M
Enterprise Value 1.64B
Income -66.39M
Sales 12.56B
FCF (ttm) 298.01M
Book/sh -11.78
Cash/sh 3.20
Employees —
Insider 10d —
IPO Sep 12, 2018
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 43.36
PEG —
P/S 0.00
P/B -0.52
P/C —
EV/EBITDA 112.20
EV/Sales 0.13
Quick Ratio 0.45
Current Ratio 1.09
Debt/Eq 101.48
LT Debt/Eq —
EPS (ttm) -1.12
EPS next Y 0.14
EPS Growth —
Revenue Growth -26.70%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-03-19
Earnings (prior) 2026-03-19
ROA -0.06%
ROE -7.57%
ROIC —
Gross Margin 3.01%
Oper. Margin -0.01%
Profit Margin -0.53%
Shs Outstand 5.20M
Shs Float 91.20M
Insider Own 8.36%
Instit Own 1.21%
Short Float 0.27%
Short Ratio 1.41
Short Interest 13.80K
52W High 11.17
vs 52W High -45.66%
52W Low 2.48
vs 52W Low 144.76%
Beta 0.66
Impl. Vol. —
Rel Volume 0.82
Avg Volume 14.01K
Volume 11.53K
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $5.77
Price $6.07
Change 5.20%
About

111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education, and brand awareness services; and marketing and channel data services. It also provides 1 Pharmacy online wholesale pharmacy that offers pharmaceutical and other health and wellness products; and 1 Medicine Marketplace online retail pharmacy that provides pharmaceutical products and other merchandise. In addition, the company offers online loan application services; cloud-based inventory management services; smart procurement services, which collect pharmacies' historical purchase orders and inventory data; and Hawkeye automated salesforce tool, as well as online consultation, e-prescription, and data services. Further, its pharmacies provide drugs, including prescription and over-the-counter drugs comprising Western and Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices that consists of bandages and thermometers; and personal care products that include skin care, birth control, sexual wellness, and baby products. Additionally, the company offers research and development, and consulting services; warehousing, procurement, and logistics services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies, medical professionals, and marketplace sellers. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$6.07
Latest analyst target
3. DCF / Fair value
$1032.18
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$6.07
Low
—
High
—
Mean
—
News
RSS: Latest YI news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
12,556.02
-12.81%
14,401.25
-3.66%
14,948.13
+10.59%
13,516.70
Operating Revenue
12,556.02
-12.81%
14,401.25
-3.66%
14,948.13
+10.59%
13,516.70
Cost Of Revenue
11,832.62
-12.82%
13,572.02
-3.74%
14,099.15
+11.22%
12,676.72
Reconciled Cost Of Revenue
11,832.62
-12.82%
13,572.02
-3.74%
14,099.15
+11.22%
12,676.72
Gross Profit
723.41
-12.76%
829.23
-2.33%
848.98
+1.07%
839.98
Operating Expense
725.78
-12.25%
827.12
-31.02%
1,199.08
-0.98%
1,210.98
Selling General And Administration
328.10
-14.74%
384.80
-42.79%
672.59
+1.37%
663.50
Selling And Marketing Expense
258.64
-17.60%
313.90
-29.99%
448.39
-2.07%
457.88
General And Administrative Expense
69.46
-2.04%
70.91
-68.37%
224.20
+9.04%
205.62
Other Gand A
69.46
-2.04%
70.91
-68.37%
224.20
+9.04%
205.62
Other Operating Expenses
397.68
-10.09%
442.31
-15.99%
526.49
-3.83%
547.47
Total Expenses
12,558.40
-12.78%
14,399.14
-5.88%
15,298.23
+10.16%
13,887.70
Operating Income
-2.38
-212.44%
2.11
+100.60%
-350.10
+5.63%
-371.00
Total Operating Income As Reported
-2.38
-212.44%
2.11
+100.60%
-350.10
+5.63%
-371.00
EBITDA
24.91
+1.19%
24.62
+107.91%
-311.26
+3.28%
-321.81
Normalized EBITDA
24.43
-4.30%
25.53
+108.19%
-311.87
+0.66%
-313.93
Reconciled Depreciation
11.84
-30.22%
16.97
-22.10%
21.78
-46.64%
40.82
EBIT
13.07
+70.83%
7.65
+102.30%
-333.04
+8.16%
-362.63
Total Unusual Items
0.48
+152.81%
-0.91
-249.02%
0.61
+107.75%
-7.88
Total Unusual Items Excluding Goodwill
0.48
+152.81%
-0.91
-249.02%
0.61
+107.75%
-7.88
Net Income
-66.39
-2.55%
-64.74
+83.51%
-392.69
+5.80%
-416.88
Pretax Income
-22.50
-8.81%
-20.68
+94.14%
-353.18
+6.09%
-376.07
Net Non Operating Interest Income Expense
-31.69
-48.84%
-21.29
-88.29%
-11.31
-112.34%
-5.33
Interest Expense Non Operating
35.57
+25.56%
28.33
+40.66%
20.14
+49.83%
13.44
Net Interest Income
-31.69
-48.84%
-21.29
-88.29%
-11.31
-112.34%
-5.33
Interest Expense
35.57
+25.56%
28.33
+40.66%
20.14
+49.83%
13.44
Interest Income Non Operating
3.88
-44.82%
7.04
-20.30%
8.83
+8.82%
8.12
Interest Income
3.88
-44.82%
7.04
-20.30%
8.83
+8.82%
8.12
Other Income Expense
11.56
+868.75%
-1.50
-118.29%
8.22
+3099.22%
0.26
Other Non Operating Income Expenses
11.08
+1962.52%
-0.59
-107.82%
7.61
-6.39%
8.13
Gain On Sale Of Security
0.48
+152.81%
-0.91
-249.02%
0.61
+107.75%
-7.88
Tax Provision
0.01
-86.46%
0.10
-61.75%
0.25
0.00
Tax Rate For Calcs
0.00
+0.00%
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.12
+152.81%
-0.23
0.00
0.00
Net Income Including Noncontrolling Interests
-22.52
-8.37%
-20.78
+94.12%
-353.43
+6.02%
-376.07
Net Income From Continuing Operation Net Minority Interest
-66.39
-2.55%
-64.74
+83.51%
-392.69
+5.80%
-416.88
Net Income From Continuing And Discontinued Operation
-66.39
-2.55%
-64.74
+83.51%
-392.69
+5.80%
-416.88
Net Income Continuous Operations
-22.52
-8.37%
-20.78
+94.12%
-353.43
+6.02%
-376.07
Minority Interests
-43.88
+0.20%
-43.97
-11.99%
-39.26
+3.80%
-40.81
Normalized Income
-66.75
-4.20%
-64.06
+83.71%
-393.30
+3.84%
-409.00
Net Income Common Stockholders
-66.39
-2.55%
-64.74
+83.51%
-392.69
+5.80%
-416.88
Diluted EPS
—
-7.60
+83.69%
-46.60
+6.80%
-50.00
Basic EPS
—
-7.60
+83.69%
-46.60
+6.80%
-50.00
Basic Average Shares
—
8.59
+1.91%
8.43
+1.19%
8.33
Diluted Average Shares
—
8.59
+1.91%
8.43
+1.19%
8.33
Diluted NI Availto Com Stockholders
-66.39
-2.55%
-64.74
+83.51%
-392.69
+5.80%
-416.88
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
2,200.24
-21.07%
2,787.75
-9.75%
3,089.04
-11.08%
3,473.81
Current Assets
2,124.86
-19.81%
2,649.66
-9.67%
2,933.33
-9.35%
3,235.82
Cash Cash Equivalents And Short Term Investments
561.00
+21.35%
462.29
-29.28%
653.67
-25.68%
879.53
Cash And Cash Equivalents
510.97
+10.53%
462.29
-23.40%
603.52
-10.41%
673.67
Other Short Term Investments
50.03
0.00
-100.00%
50.14
-75.64%
205.86
Receivables
434.93
-31.04%
630.72
-18.78%
776.51
+7.79%
720.36
Accounts Receivable
259.69
-37.14%
413.10
-23.05%
536.82
+9.81%
488.88
Gross Accounts Receivable
266.04
-36.10%
416.32
-23.06%
541.11
+9.87%
492.50
Allowance For Doubtful Accounts Receivable
-6.36
-97.18%
-3.22
+24.73%
-4.28
-17.96%
-3.63
Other Receivables
74.84
-9.79%
82.96
-23.05%
107.81
-21.03%
136.52
Taxes Receivable
41.79
-25.16%
55.84
+2.86%
54.28
+5.13%
51.63
Inventory
998.47
-28.03%
1,387.40
-2.25%
1,419.40
-5.30%
1,498.90
Finished Goods
998.47
-28.03%
1,387.40
-2.25%
1,419.40
-5.30%
1,498.90
Prepaid Assets
63.46
-40.37%
106.43
+95.90%
54.33
-37.12%
86.40
Restricted Cash
50.34
-10.18%
56.04
+179.87%
20.02
-53.56%
43.12
Other Current Assets
16.67
+146.08%
6.78
-27.95%
9.40
+25.22%
7.51
Total Non Current Assets
75.38
-45.41%
138.09
-11.31%
155.71
-34.57%
237.99
Net PPE
65.23
-46.52%
121.97
-11.70%
138.14
-34.95%
212.37
Gross PPE
145.41
-27.72%
201.17
-26.52%
273.78
-16.98%
329.77
Accumulated Depreciation
-80.18
-1.25%
-79.20
+41.61%
-135.64
-15.54%
-117.40
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
44.12
-50.46%
89.07
-14.19%
103.80
-36.66%
163.88
Machinery Furniture Equipment
—
—
—
—
Construction In Progress
—
—
—
—
Other Properties
101.29
-9.64%
112.10
-59.06%
273.78
+65.03%
165.90
Leases
—
—
—
—
Goodwill And Other Intangible Assets
0.87
-39.60%
1.44
-36.30%
2.26
-30.95%
3.27
Investments And Advances
—
0.00
-100.00%
2.00
+0.00%
2.00
Other Non Current Assets
9.29
-36.76%
14.68
+10.31%
13.31
-34.59%
20.35
Total Liabilities Net Minority Interest
1,985.82
-17.50%
2,406.99
-14.43%
2,812.93
-0.45%
2,825.58
Current Liabilities
1,953.67
-16.60%
2,342.58
-14.66%
2,745.06
+0.73%
2,725.11
Payables And Accrued Expenses
1,557.17
-16.50%
1,864.89
-6.41%
1,992.56
+1.28%
1,967.28
Payables
1,508.92
-16.50%
1,807.05
-5.61%
1,914.41
+1.44%
1,887.28
Accounts Payable
1,282.37
-25.51%
1,721.42
+8.35%
1,588.69
-9.98%
1,764.85
Other Payable
223.70
+174.82%
81.40
-74.46%
318.77
+276.39%
84.69
Current Accrued Expenses
48.25
-16.58%
57.84
-25.99%
78.14
-2.32%
80.00
Total Tax Payable
2.85
-32.51%
4.22
-39.19%
6.95
-81.59%
37.73
Current Debt And Capital Lease Obligation
206.75
+2.70%
201.32
-47.10%
380.61
+56.16%
243.72
Current Debt
187.63
+16.55%
160.98
-52.38%
338.07
+88.88%
178.99
Current Capital Lease Obligation
19.12
-52.61%
40.34
-5.15%
42.53
-34.30%
64.73
Current Deferred Liabilities
143.69
-22.69%
185.87
+21.09%
153.50
-52.56%
323.57
Current Deferred Revenue
143.69
-22.69%
185.87
+21.09%
153.50
-52.56%
323.57
Other Current Liabilities
46.06
-49.10%
90.50
-58.56%
218.40
+14.63%
190.54
Total Non Current Liabilities Net Minority Interest
32.15
-50.09%
64.41
-5.10%
67.87
-32.45%
100.47
Long Term Debt And Capital Lease Obligation
29.96
-45.96%
55.45
-11.46%
62.62
-37.67%
100.47
Long Term Capital Lease Obligation
29.96
-45.96%
55.45
-11.46%
62.62
-37.67%
100.47
Other Non Current Liabilities
2.18
-75.66%
8.96
+70.85%
5.25
—
Stockholders Equity
-702.23
-9.27%
-642.64
-10.15%
-583.45
-40.73%
-414.60
Common Stock Equity
-702.23
-9.27%
-642.64
-10.15%
-583.45
-40.73%
-414.60
Capital Stock
0.06
+1.72%
0.06
+1.75%
0.06
+1.79%
0.06
Common Stock
0.06
+1.72%
0.06
+1.75%
0.06
+1.79%
0.06
Share Issued
176.04
+1.63%
173.21
+1.07%
171.38
+1.19%
169.37
Ordinary Shares Number
175.70
+1.63%
172.88
+1.07%
171.04
+2.40%
167.03
Treasury Shares Number
0.33
+0.00%
0.33
+0.00%
0.33
-85.71%
2.33
Additional Paid In Capital
3,181.34
+0.27%
3,172.82
+0.12%
3,169.11
+6.45%
2,977.17
Retained Earnings
-3,950.38
-1.71%
-3,883.99
-1.70%
-3,819.25
-11.46%
-3,426.56
Gains Losses Not Affecting Retained Earnings
72.64
-2.32%
74.36
+2.54%
72.51
-4.06%
75.59
Treasury Stock
5.89
+0.00%
5.89
+0.00%
5.89
-85.59%
40.86
Minority Interest
916.65
-10.43%
1,023.41
+19.06%
859.55
-19.13%
1,062.83
Other Equity Adjustments
72.64
-2.32%
74.36
+2.54%
72.51
-4.06%
75.59
Total Equity Gross Minority Interest
214.42
-43.69%
380.76
+37.91%
276.10
-57.41%
648.24
Total Capitalization
-702.23
-9.27%
-642.64
-10.15%
-583.45
-40.73%
-414.60
Working Capital
171.18
-44.25%
307.08
+63.11%
188.27
-63.14%
510.71
Invested Capital
-514.60
-6.84%
-481.66
-96.30%
-245.38
-4.15%
-235.61
Total Debt
236.71
-7.81%
256.77
-42.07%
443.23
+28.77%
344.19
Capital Lease Obligations
49.08
-48.76%
95.79
-8.91%
105.15
-36.35%
165.20
Net Tangible Assets
-703.10
-9.16%
-644.08
-9.97%
-585.71
-40.17%
-417.87
Tangible Book Value
-703.10
-9.16%
-644.08
-9.97%
-585.71
-40.17%
-417.87
Line Of Credit
187.63
+16.55%
160.98
-52.38%
338.07
+88.88%
178.99
Notes Receivable
58.62
-25.64%
78.83
+1.58%
77.60
+79.08%
43.33
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
119.14
-54.70%
263.02
+158.81%
-447.24
-1831.77%
-23.15
Cash Flow From Continuing Operating Activities
119.14
-54.70%
263.02
+158.81%
-447.24
-1831.77%
-23.15
Net Income From Continuing Operations
-22.52
-8.37%
-20.78
+94.12%
-353.43
+6.02%
-376.07
Depreciation Amortization Depletion
11.84
-30.22%
16.97
-22.10%
21.78
-46.64%
40.82
Depreciation
11.27
-30.21%
16.15
-22.23%
20.77
-46.86%
39.08
Amortization Cash Flow
0.57
-30.31%
0.81
-19.39%
1.01
-41.83%
1.74
Depreciation And Amortization
11.84
-30.22%
16.97
-22.10%
21.78
-46.64%
40.82
Amortization Of Intangibles
0.57
-30.31%
0.81
-19.39%
1.01
-41.83%
1.74
Other Non Cash Items
38.70
-20.20%
48.50
-22.54%
62.61
-9.68%
69.32
Stock Based Compensation
10.05
-50.14%
20.15
-91.11%
226.69
+39.87%
162.07
Provisionand Write Offof Assets
3.18
+512.91%
0.52
-73.38%
1.95
-27.62%
2.69
Asset Impairment Charge
1.81
-53.51%
3.89
-80.48%
19.91
-30.14%
28.50
Operating Gains Losses
-1.15
-203.60%
1.11
+145.85%
-2.42
-147.97%
5.05
Gain Loss On Investment Securities
-0.71
-517.65%
0.17
+104.22%
-4.03
+4.49%
-4.21
Net Foreign Currency Exchange Gain Loss
-0.48
-152.75%
0.91
+49.18%
0.61
-92.25%
7.88
Gain Loss On Sale Of PPE
0.04
+25.81%
0.03
-96.88%
0.99
-28.63%
1.39
Change In Working Capital
77.23
-59.91%
192.66
+145.40%
-424.33
-1054.32%
44.46
Change In Receivables
170.73
+39.97%
121.97
+244.92%
-84.16
-112.67%
-39.58
Changes In Account Receivables
150.52
+22.17%
123.20
+346.91%
-49.90
+42.63%
-86.98
Change In Inventory
387.13
+1277.35%
28.11
-52.84%
59.59
+114.67%
-406.29
Change In Prepaid Assets
54.43
+307.63%
-26.21
-145.86%
57.16
+244.75%
-39.49
Change In Payables And Accrued Expense
-535.66
-632.81%
100.53
+124.72%
-406.71
-168.34%
595.14
Change In Accrued Expense
-96.60
-200.02%
-32.20
+86.00%
-229.97
-229.46%
177.64
Change In Payable
-439.06
-430.78%
132.73
+175.10%
-176.74
-142.33%
417.50
Change In Account Payable
-439.06
-430.78%
132.73
+175.10%
-176.74
-142.33%
417.50
Change In Other Working Capital
-6.78
-282.50%
3.71
-29.17%
5.25
+441.25%
-1.54
Change In Other Current Assets
5.40
+493.29%
-1.37
-119.49%
7.04
+304.95%
1.74
Change In Other Current Liabilities
1.99
+105.83%
-34.08
+45.47%
-62.50
+4.62%
-65.52
Investing Cash Flow
-53.72
-243.74%
37.38
-75.37%
151.74
+421.67%
-47.17
Cash Flow From Continuing Investing Activities
-53.72
-243.74%
37.38
-75.37%
151.74
+421.67%
-47.17
Net PPE Purchase And Sale
-4.37
+70.36%
-14.74
-80.34%
-8.17
+73.10%
-30.39
Purchase Of PPE
-4.45
+70.72%
-15.20
-54.74%
-9.82
+68.89%
-31.57
Sale Of PPE
0.08
-82.10%
0.46
-72.21%
1.65
+39.07%
1.19
Capital Expenditure
-4.45
+70.72%
-15.20
-54.70%
-9.82
+68.99%
-31.69
Net Investment Purchase And Sale
-49.35
-194.70%
52.12
-67.41%
159.92
+1266.28%
-13.71
Purchase Of Investment
-750.00
-63.04%
-460.00
+49.69%
-914.33
+27.94%
-1,268.92
Sale Of Investment
700.64
+36.81%
512.12
-52.33%
1,074.25
-14.42%
1,255.21
Net Business Purchase And Sale
—
0.00
0.00
+100.00%
-2.96
Purchase Of Business
—
0.00
0.00
+100.00%
-2.96
Net Intangibles Purchase And Sale
0.00
0.00
+100.00%
-0.00
+97.37%
-0.11
Purchase Of Intangibles
0.00
0.00
+100.00%
-0.00
+97.37%
-0.11
Financing Cash Flow
-21.19
+94.78%
-406.24
-297.22%
205.98
+806.00%
22.73
Cash Flow From Continuing Financing Activities
-21.19
+94.78%
-406.24
-297.22%
205.98
+806.00%
22.73
Net Issuance Payments Of Debt
26.65
+115.05%
-177.09
-204.48%
169.51
+310.13%
-80.67
Issuance Of Debt
287.63
-34.46%
438.86
-52.28%
919.63
+16.68%
788.15
Repayment Of Debt
-260.98
+57.63%
-615.96
+17.89%
-750.13
+13.66%
-868.82
Long Term Debt Issuance
—
—
—
—
Net Long Term Debt Issuance
—
—
—
—
Short Term Debt Issuance
287.63
-34.46%
438.86
-52.28%
919.63
+16.68%
788.15
Short Term Debt Payments
-260.98
+57.63%
-615.96
+17.89%
-750.13
+13.66%
-868.82
Net Short Term Debt Issuance
26.65
+115.05%
-177.09
-204.48%
169.51
+310.13%
-80.67
Net Common Stock Issuance
0.74
+5221.43%
0.01
-93.72%
0.22
-18.61%
0.27
Common Stock Payments
—
—
0.00
0.00
Repurchase Of Capital Stock
—
—
0.00
0.00
Net Other Financing Charges
-48.59
+78.80%
-229.16
-732.21%
36.25
-64.85%
103.13
Changes In Cash
44.23
+141.78%
-105.84
-18.23%
-89.52
-88.11%
-47.59
Effect Of Exchange Rate Changes
-1.25
-299.52%
0.63
+116.88%
-3.72
-200.30%
3.71
Beginning Cash Position
518.33
-16.87%
623.55
-13.01%
716.79
-5.77%
760.67
End Cash Position
561.30
+8.29%
518.33
-16.87%
623.55
-13.01%
716.79
Free Cash Flow
114.69
-53.72%
247.82
+154.22%
-457.07
-733.46%
-54.84
Interest Paid Supplemental Data
2.42
-60.74%
6.16
-40.93%
10.42
+9.15%
9.55
Income Tax Paid Supplemental Data
0.01
-86.46%
0.10
-61.75%
0.25
0.00
Common Stock Issuance
0.74
+5221.43%
0.01
-93.72%
0.22
-18.61%
0.27
Earnings Losses From Equity Investments
—
—
—
—
Issuance Of Capital Stock
0.74
+5221.43%
0.01
-93.72%
0.22
-18.61%
0.27
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category